196 related articles for article (PubMed ID: 11478093)
1. Phase I cancer trials: therapeutic research?
Kodish E
Hastings Cent Rep; 2001; 31(1):4-5. PubMed ID: 11478093
[No Abstract] [Full Text] [Related]
2. Phase I cancer trials: therapeutic research?
Wells RJ
Hastings Cent Rep; 2001; 31(1):4; author reply 5. PubMed ID: 11478096
[No Abstract] [Full Text] [Related]
3. Phase I cancer trials. A collusion of misunderstanding.
Miller M
Hastings Cent Rep; 2000; 30(4):34-43. PubMed ID: 10971892
[No Abstract] [Full Text] [Related]
4. Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents.
Ratain MJ; Mick R; Schilsky RL; Siegler M
J Natl Cancer Inst; 1993 Oct; 85(20):1637-43. PubMed ID: 8411243
[No Abstract] [Full Text] [Related]
5. Dying for a cure. Why cancer patients often turn to risky, experimental treatments--and wind up paying with their lives.
Kaplan S; Brownlee S
US News World Rep; 1999 Oct; 127(14):34-7, 40-3. PubMed ID: 10621514
[No Abstract] [Full Text] [Related]
6. Subject selection for clinical trials.
American Medical Association. Council on Ethical and Judicial Affairs
IRB; 1998; 20(2-3):12-5. PubMed ID: 11656913
[No Abstract] [Full Text] [Related]
7. Human subjects in weapons research.
Caplan AL; Sankar P
Science; 2002 Nov; 298(5595):923. PubMed ID: 12411671
[No Abstract] [Full Text] [Related]
8. An appraisal of human experimentation in international law and practice: the need for international regulation of human experimentation.
Bassiouni MC; Baffes TG; Evrard JT
J Crim Law Criminol; 1981; 72(4):1597-666. PubMed ID: 11649443
[No Abstract] [Full Text] [Related]
9. Dying children and medical research: access to clinical trials as benefit and burden.
Oberman M; Frader J
Am J Law Med; 2003; 29(2-3):301-17. PubMed ID: 12961809
[No Abstract] [Full Text] [Related]
10. The clinical-trials bottleneck.
Russo F
Atl Mon; 1999 May; 283(5):30, 32, 34, 36. PubMed ID: 11657639
[No Abstract] [Full Text] [Related]
11. [Continual reassessment method (CRM)].
Ishizuka N
Gan To Kagaku Ryoho; 2000 Aug; 27(9):1449-57. PubMed ID: 10969605
[TBL] [Abstract][Full Text] [Related]
12. Modern medical research ethics.
Tranøy KE
Scand J Prim Health Care Suppl; 1993 Sep; 11(3):161-2. PubMed ID: 11654192
[No Abstract] [Full Text] [Related]
13. Phase I trials in cancer treatment. The maximum tolerated dose: a barbarian guideline.
Degos L
Hematol J; 2000; 1(4):219. PubMed ID: 11920193
[No Abstract] [Full Text] [Related]
14. The sex kitten of bioethics? Research ethics comes of age.
Dresser R
Hastings Cent Rep; 2008; 38(5):5. PubMed ID: 18947127
[No Abstract] [Full Text] [Related]
15. [Research. Patients in research studies are poorly informed].
Scocozza L
Sygeplejersken; 1990 Jan; 90(3):8-14. PubMed ID: 2180098
[No Abstract] [Full Text] [Related]
16. Referral and decision making among advanced cancer patients participating in Phase I trials at a single institution.
Gordon EJ; Daugherty CK
J Clin Ethics; 2001; 12(1):31-8. PubMed ID: 11428154
[No Abstract] [Full Text] [Related]
17. Thinking clearly about research risk: implications of the work of Benjamin Freedman.
Weijer C
IRB; 1999; 21(6):1-5. PubMed ID: 11697392
[No Abstract] [Full Text] [Related]
18. Therapeutic misconception in early phase gene transfer trials.
Henderson GE; Easter MM; Zimmer C; King NM; Davis AM; Rothschild BB; Churchill LR; Wilfond BS; Nelson DK
Soc Sci Med; 2006 Jan; 62(1):239-53. PubMed ID: 16000230
[TBL] [Abstract][Full Text] [Related]
19. 3 + 3 not equal to (Rolling) 6.
Hartford C; Volchenboum SL; Cohn SL
J Clin Oncol; 2008 Jan; 26(2):170-1. PubMed ID: 18182656
[No Abstract] [Full Text] [Related]
20. [Guideline for phase I study on new anticancer agents].
Shimoyama M
Gan To Kagaku Ryoho; 2001 Feb; 28(2):261-70. PubMed ID: 11242659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
